Thursday
SESSION 20: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2011: WHERE IS IT AND WHERE IS IT GOING (5-MINUTE TALKS)
SESSION 20 SCHEDULE
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR
2:11 PM - 2:16 PM Tips And Tricks For Performing CAS Under Difficult Circumstances: Limitations Of Current Platforms And How Will They Be Improved
  Presenter(s):Bernhard Reimers, MD  
2:17 PM - 2:22 PM Tips And Tricks To Make CAS Safer: Why Do Most Strokes Occur After Embolic Protection Devices Are Out: How Can CAS Stroke Rates Best Be Decreased
  Presenter(s):Emmanuel M. Houdart, MD  
2:23 PM - 2:28 PM Beyond Technique And Embolic Protection How Can We Prevent Strokes With CAS: Where Do We Stand With Mesh Or Membrane Covered Stents
  Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
2:29 PM - 2:34 PM Safety Of CAS WITHOUT Embolic Protection Devices: Why Do We Ignore The Evidence
  Presenter(s):Jos C. van den Berg, MD, PhD  
2:35 PM - 2:40 PM DEBATE: CAS Is The Treatment Of Choice For Most Symptomatic And Asymptomatic High-Grade Stenosis: A CAS Enthusiast Interprets CREST
  Presenter(s):William A. Gray, MD  
2:41 PM - 2:46 PM DEBATE: CEA Is Best For Most Symptomatic And Some Asymptomatic Carotid Stenosis Patients: A CEA Enthusiast Interprets CREST
  Presenter(s):Wesley S. Moore, MD  
2:47 PM - 2:52 PM DEBATE: Best Medical Treatment Is Best For Most Asymptomatic Cases: A Best Medical Treatment Enthusiast Interprets CREST And Other Data
  Presenter(s):Peter R.F. Bell, MD, FRCS, DSC, KBE  
2:53 PM - 2:58 PM The ICSS Trial: Why Were The Results Of ICSS So Different From CREST, Or Were They: Why Is ICSS Ignored In The U.S.
  Presenter(s):Jonathan D. Beard, MD  
2:59 PM - 3:04 PM It Is Not Possible To Justify CAS For Patients With Atherosclerotic Carotid Disease
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
3:05 PM - 3:11 PM Panel Discussion
Moderator(s): Peter R.F. Bell, MD, FRCS, DSC, KBE / Giorgio M. Biasi, MD  
3:11 PM - 3:16 PM DEBATE: Current Medical Intervention Alone Is Superior To CEA And CAS For Asymptomatic Carotid Arterial Disease
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
3:17 PM - 3:22 PM DEBATE: We Can Now Select Asymptomatic Carotid Stenosis Patients Who Require CEA Or CAS With Confidence
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
3:23 PM - 3:28 PM Do Statins And Medical Therapy Reduce Carotid Plaque Size, Embolic Potential And The Risk Of Stroke
  Presenter(s):Christos D. Liapis, MD  
3:29 PM - 3:34 PM Details Of CREST Data With Regard To Patients’ Symptomatic Status And Quality Of Life: Does A Minor MI Have More Serious Implications For Longevity Than A Minor Stroke – As Some Have Claimed
  Presenter(s):Thomas G. Brott, MD  
3:35 PM - 3:40 PM The AHA/ACC/ASA/SVS/Etc. Guidelines Are Misguided: CAS Is Not Yet An “Alternative” To CEA For Most Symptomatic Patients
  Presenter(s):Frank J. Veith, MD  
3:41 PM - 3:46 PM Carotid Stenosis Is A Rare Cause Of Stroke With Cardiac Surgery: Rarely Is CEA Or CAS Needed Before Or With Cardiac Surgery: When Is That
  Presenter(s):A. Ross Naylor, MD, FRCS  
3:47 PM - 4:00 PM Panel Discussion/Break
Visit Exhibits and Pavilions (2nd and 3rd Floors)

END OF SESSION 20
previous next